Day One Biopharmaceuticals Q4 2025 Earnings EPS Miss Amid Continued RD Investment BIO Q1 2026 Earnings EPS Falls Short of Estimates Shares Gain ACR Q1 2026 Earnings EPS Misses Estimates Amid Challenging Commercial Real Estate Environment Nabors Industries Q1 2026 Earnings Earnings Beat Estimates but Stock Slips Ducommun DCO Q1 2026 Earnings EPS Falls Short of Estimates Stock Edges Higher LITS Q4 2024 Earnings EPS Misses Estimates by Wide Margin Stock Declines